Utah Medical Products, Inc.
UTMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$216M
Close$
$92.07
31.8% upside
Current Fair Value
31.8% upsideUndervalued by 31.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $216.00 Million |
|---|---|
| Enterprise Value | $128.81 Million |
| Dividend Yield | $1.23 (1.81%) |
| Earnings per Share | $3.41 |
| Beta | 0.37 |
| Outstanding Shares | 3,185,000 |
Return
| Return on Equity | 9.01% |
|---|---|
| Return on Assets | 8.72% |
| Return on Invested Capital | 10.60% |
Valuation & Multiples
| P/E Ratio | 19.92 |
|---|---|
| PEG | -138.61 |
| Price to Sales | 6.35 |
| Price to Book Ratio | 1.89 |
| Enterprise Value to Revenue | 3.43 |
| Enterprise Value to EBIT | 10.05 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
July 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 68.47%▲ 5.03% |
|---|---|
| Total Invested | $140.49M▲ 19.54% |
| Investors Holding | 119▲ 2.00% |
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...